Explore All Access
Check if your research matches the topics covered in Kidney Cancer?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Kidney Cancer : Impact Factor & More
eISSN: 2468-4570pISSN: 2468-4562
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Kidney Cancer Key Metrics
CiteScore 
2
H-Index
9
SJR
Q3Oncology
SNIP
0.49
Topics Covered on Kidney Cancer
Immunotherapy
Renal function
Nephrectomy
Renal carcinoma
Overall survival
Systematic review
Immune checkpoint inhibitors
Systemic therapy
Surgical treatment
Cytoreductive nephrectomy
Fda approval
Cabozantinib
Nivolumab
Progression-free survival
Survival rate
Genitourinary cancer
Kidney Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | IOS PRESS |
| Language | English |
| Frequency | Semi-annual |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Kidney Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Kidney Cancer
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations.
- 5 Sep 2024
- Kidney cancer (Clifton, Va.)
Perspectives on Neoadjuvant Clinical Trial Participation for Patients with Kidney Cancer: A Survey-Based Examination
- 19 Aug 2024
- Kidney Cancer
Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review.
- 7 Aug 2024
- Kidney cancer (Clifton, Va.)
Real-World Outcomes in Patients with Advanced/Metastatic Renal Cell Carcinoma Receiving Cabozantinib or Other Tyrosine Kinase Inhibitors After Checkpoint Inhibitor-Based Therapy
- 2 Aug 2024
- Kidney Cancer
Durability of Response with First-Line Combined Immune Checkpoint Inhibitor Therapy Compared to Checkpoint Inhibitor with VEGFR-TKI in Advanced Clear Cell Renal Cell Carcinoma
- 21 Jun 2024
- Kidney Cancer
Papillary Renal Cell Carcinoma: Current Evidence and Future Directions
- 7 May 2024
- Kidney Cancer
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations.
- 5 Sep 2024
- Kidney cancer (Clifton, Va.)
Perspectives on Neoadjuvant Clinical Trial Participation for Patients with Kidney Cancer: A Survey-Based Examination
- 19 Aug 2024
- Kidney Cancer
Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review.
- 7 Aug 2024
- Kidney cancer (Clifton, Va.)
Real-World Outcomes in Patients with Advanced/Metastatic Renal Cell Carcinoma Receiving Cabozantinib or Other Tyrosine Kinase Inhibitors After Checkpoint Inhibitor-Based Therapy
- 2 Aug 2024
- Kidney Cancer
Durability of Response with First-Line Combined Immune Checkpoint Inhibitor Therapy Compared to Checkpoint Inhibitor with VEGFR-TKI in Advanced Clear Cell Renal Cell Carcinoma
- 21 Jun 2024
- Kidney Cancer
Papillary Renal Cell Carcinoma: Current Evidence and Future Directions
- 7 May 2024
- Kidney Cancer
Compare Similar Journals with Kidney Cancer
Select Journals to Compare with Kidney Cancer
Total journals - 6
You can select up to 3 Journals at a time
0 Journals Selected to compare with
Kidney Cancer
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Kidney Cancer
How long has Kidney Cancer been actively publishing? 
Kidney Cancer has been in operation since 2017 till date.
What is the publishing frequency of Kidney Cancer?
Kidney Cancer published with a Semi-annual frequency.
How many articles did Kidney Cancer publish last year?
In 2023, Kidney Cancer publsihed 16 articles.
What is the eISSN & pISSN for Kidney Cancer?
For Kidney Cancer, eISSN is 2468-4570 and pISSN is 2468-4562.
What is Citescore for Kidney Cancer?
Citescore for Kidney Cancer is 2.
What is the H Index for Kidney Cancer ?
H Index for Kidney Cancer is 9.
What is SNIP score for Kidney Cancer?
SNIP score for Kidney Cancer is 0.49.
What is the SJR for Kidney Cancer?
SJR for Kidney Cancer is Q3.
Who is the publisher of Kidney Cancer?
IOS PRESS is the publisher of Kidney Cancer.
